Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.

Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI.

Circulation. 2006 May 16;113(19):2278-84. Epub 2006 May 8.

2.

Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.

Czyz A, Kołacz E, Angerer D, Zawilska K.

Kardiol Pol. 2005 Mar;62(3):189-200; discussion 201. English, Polish.

PMID:
15830013
3.
5.

Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study.

Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP; PREVENT study.

J Am Coll Cardiol. 2004 Nov 16;44(10):1996-2002.

6.

Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.

van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH.

Am J Cardiol. 2006 Jun 15;97(12):1697-701. Epub 2006 Apr 21.

PMID:
16765116
7.

Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.

Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.

Coron Artery Dis. 2008 May;19(3):187-93. doi: 10.1097/MCA.0b013e3282f399e2.

PMID:
18418236
8.

Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.

Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI.

Am Heart J. 2008 Jan;155(1):49-55. Epub 2007 Nov 1.

9.

Immature platelets in patients with acute coronary syndromes.

Grove EL, Hvas AM, Kristensen SD.

Thromb Haemost. 2009 Jan;101(1):151-6.

PMID:
19132202
10.

Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI).

Lund J, Qin QP, Ilva T, Nikus K, Eskola M, Porela P, Kokkala S, Pulkki K, Pettersson K, Voipio-Pulkki LM.

Ann Med. 2006;38(3):221-8.

PMID:
16720436
11.

IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.

Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1503-8. Epub 2004 Jun 3.

12.

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, Lubos E, Münzel T, Peetz D, Nicaud V, Juhan-Vague I, Tiret L; Atherogene Investigators.

J Thromb Haemost. 2007 Mar;5(3):475-82. Epub 2007 Jan 4.

13.

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, Amouyel P, Evans A, Cambien F, Tiret L; PRIME Study Group.

Circulation. 2003 Nov 18;108(20):2453-9. Epub 2003 Oct 27.

14.

Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.

Saraf S, Christopoulos C, Salha IB, Stott DJ, Gorog DA.

J Am Coll Cardiol. 2010 May 11;55(19):2107-15. doi: 10.1016/j.jacc.2010.01.033.

15.

Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.

Canale ML, Stroppa S, Caravelli P, Petronio AS, Mariotti R, Mariani M, Balbarini A, Barsotti A.

Coron Artery Dis. 2006 Dec;17(8):693-8.

PMID:
17119378
16.

Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.

Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I.

Circulation. 2007 Apr 3;115(13):1769-76. Epub 2007 Mar 12.

17.

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005.

PMID:
19595394
18.

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J; PEACE Investigators.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2463-9. Epub 2007 Aug 31.

19.

Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.

Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, Freedman M, Metivier J, Cannata R, O'Donnell CJ, Kottke-Marchant K, Murugesan G, Plow EF, Stenina O, Daley GQ.

Circulation. 2001 Nov 27;104(22):2641-4.

20.

Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.

Mälarstig A, Silveira A, Wågsäter D, Öhrvik J, Bäcklund A, Samnegård A, Khademi M, Hellenius ML, Leander K, Olsson T, Uhlén M, de Faire U, Eriksson P, Hamsten A.

J Intern Med. 2011 Sep;270(3):229-36. doi: 10.1111/j.1365-2796.2011.02364.x. Epub 2011 Mar 21.

Supplemental Content

Support Center